Flublok Quadrivalent (Protein Sciences Corporation)


Welcome to the PulseAid listing for the Flublok Quadrivalent drug offered from Protein Sciences Corporation. This pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: Protein Sciences Corporation
NON-PROPRIETARY NAME: influenza vaccine
SUBSTANCE NAME: INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/HONG KONG/4801/2014 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/BRISBANE/60/2008 RE
TYPE: VACCINE
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2017-07-14
END MARKETING DATE: 0000-00-00


Flublok Quadrivalent VACCINE Details:

Item DescriptionFlublok Quadrivalent from Protein Sciences Corporation
LABELER NAME: Protein Sciences Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 45; 45; 45; 45(ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL)
START MARKETING DATE: 2017-07-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42874-117_1f23f0c1-6770-4f73-bd0b-0772a652bde4
PRODUCT NDC: 42874-117
APPLICATION NUMBER: BLA125285

Other INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/HONG KONG/4801/2014 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/BRISBANE/60/2008 RE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Protein Sciences CorporationFlublok